annb0t
Top 20
The company plans an estimated 56 clinical trial locations nationwide
MELBOURNE, Australia, March 17, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals (ASX: PAR) a global biopharmaceutical company driven to improve patients' lives through repurposing existing drugs and pioneering new solutions for unmet medical needs, is announcing today the official launch of their U.S. clinical trial program with an estimated 56 planned clinical trial locations nationwide for the conduct of the pivotal phase ...
>>> Read more: Paradigm Biopharmaceuticals Initiates a Phase 3 Clinical Trial in Knee Osteoarthritis Across the U.S
MELBOURNE, Australia, March 17, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals (ASX: PAR) a global biopharmaceutical company driven to improve patients' lives through repurposing existing drugs and pioneering new solutions for unmet medical needs, is announcing today the official launch of their U.S. clinical trial program with an estimated 56 planned clinical trial locations nationwide for the conduct of the pivotal phase ...
>>> Read more: Paradigm Biopharmaceuticals Initiates a Phase 3 Clinical Trial in Knee Osteoarthritis Across the U.S
